GAPDH and cervical carcinoma: This negative correlation of the GAPDH antibody level with different stages of cervical lesion can function as an important biomarker in cervical cancer, especially when combined with additional markers, such as the presence of antibodies to the human papillomavirus (HPV), a pathogen found in nearly all cervical cancer patients [115].